Both in Pharmaceuticals
Jaguar Health vs PMGC Holdings
Over the past year JAGX returned −99.5% and ELAB returned −99.8%; their daily moves had a correlation of -0.01.
JAGX −99.5% ELAB −99.8%Growth of $1, one year, split-adjusted
| Metric | JAGX | ELAB |
|---|---|---|
| Price | $2.24 | $2.66 |
| Market cap | $4.3M | $2.2M |
| Today | −1.97% | −4.32% |
| 1 month | −49.8% | −41.3% |
| 6 months | −97.8% | −91.0% |
| Year to date | −99.0% | −99.3% |
| 1 year | −99.5% | −99.8% |
| Revenue growth (YoY) | −58.9% | — |
| Gross margin | 15.8% | 29.5% |
| Net margin | −1036.8% | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | 0.2× | 0.8× |
| Net cash | -$11.8M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 1,065.1% | 677.0% |
| Short % of float | 1.2% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).